Valuation: Net Medical Xpress Solutions, Inc.

Market Cap 1.07M 958K 882K 800K 1.52M 101M 1.55M 10.55M 4.2M 53.88M 4.03M 3.94M 170M P/E 2015
32.9x
P/E 2016 -5.75x
Enterprise Value 827K 738K 679K 616K 1.17M 77.48M 1.2M 8.12M 3.24M 41.48M 3.1M 3.04M 131M EV / Sales 2015
1.04x
EV / Sales 2016 0.65x
Free-Float
100%
Yield 2015 *
-
Yield 2016 -
1 week-85.73%
Current month-85.73%
1 month-85.73%
3 months-85.73%
6 months-85.71%
Current year-66.67%
1 week 0
Extreme 0.0001
0
1 month 0
Extreme 0.0001
0
Current year 0
Extreme 0.0001
0
1 year 0
Extreme 0.0001
0
3 years 0
Extreme 1.0E-6
0.02
5 years 0
Extreme 1.0E-6
0.75
10 years 0
Extreme 0
0.75
Manager TitleAgeSince
President - 2019-06-25
Director TitleAgeSince
Director/Board Member 64 2002-12-31
Director/Board Member 84 2004-12-31
Director/Board Member - 2018-02-28
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-85.73%-.--%-99.50% 18.83K
+3.08%+7.45%+7.69%+51.07% 3,940B
+5.89%-5.66%-13.10%+820.85% 386B
+2.87%-0.36%-50.67%+5.89% 362B
+0.43%+0.55%-2.13%+57.10% 271B
+5.53%-7.03%+51.01%+169.58% 256B
+5.27%-7.10%+61.16%+371.02% 223B
+4.89%+78.99%-37.11%+932.31% 130B
+1.44%-2.64%-40.43%-16.73% 106B
-0.67%-5.00%-27.35%-58.65% 93.14B
Average +2.86%+1.36%-5.09%+223.29% 576.75B
Weighted average by Cap. +3.28%-0.11%+3.70%+134.50%

Financials

2015 2016
Net sales 4.22M 3.77M 3.47M 3.15M 5.96M 396M 6.11M 41.48M 16.53M 212M 15.85M 15.51M 667M 3.04M 2.72M 2.5M 2.27M 4.3M 285M 4.41M 29.92M 11.92M 153M 11.43M 11.18M 481M
Net income 151K 135K 124K 113K 213K 14.15M 219K 1.48M 591K 7.58M 567K 555K 23.87M -344K -307K -283K -256K -486K -32.24M -498K -3.38M -1.35M -17.26M -1.29M -1.26M -54.37M
Net Debt -340K -303K -279K -253K -480K -31.87M -492K -3.34M -1.33M -17.06M -1.28M -1.25M -53.74M -247K -220K -203K -184K -349K -23.15M -358K -2.43M -967K -12.39M -927K -907K -39.04M
Logo Net Medical Xpress Solutions, Inc.
Net Medical Xpress Solutions, Inc. focuses on the development of artificial intelligence software named PrivateAI (Private Eye), developing clinical trials, and expanding immune defense products to different markets. The Company is also focusing on productizing hand-labeled image data for use in artificial intelligence training, verification, and validation of custom models. It focuses on artificial intelligence for medical research, clinical trials, and Food and Drug Administration (FDA) compliance, which includes cybersecurity audit products designed to meet the FDA's new mandates for connected devices. Through its subsidiary, Immunity Science, Inc., the Company provides a variety of over-the-counter vitamins, supplements, air purifiers, nasal sprays, and drug-free pain patches. It offers its products through the Website www.immunityscience.store direct to consumers. In addition, products are available from distribution centers at retail locations.
Employees
23
Date Price Change Volume
  1. Stock Market
  2. Stocks
  3. NMXS Stock